Literature DB >> 8285839

Hepatocellular adenoma in glycogen storage disease type IV.

N S Alshak1, J Cocjin, L Podesta, R van de Velde, L Makowka, P Rosenthal, S A Geller.   

Abstract

The development of hepatocellular adenoma has been recognized in association with glycogen storage disease type I and, less often, with glycogen storage disease type III, but, to our knowledge, it has not been reported in glycogen storage disease type IV. We had the opportunity to study an 11-month-old male infant who underwent orthotopic liver transplantation for cirrhosis that developed in the setting of glycogen storage disease type IV. A clinically unsuspected hepatocellular adenoma was present in the explanted liver. Glycogen storage disease type IV should be considered as a potential precursor to the development of hepatocellular adenoma. Recognition of this association is important, both in terms of the differential diagnosis of tumors that occur in this setting and also to anticipate potential complications of this benign neoplasm.

Entities:  

Mesh:

Year:  1994        PMID: 8285839

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  11 in total

1.  Hepatocellular carcinoma in glycogen storage disease type IV.

Authors:  R A de Moor; J J Schweizer; B van Hoek; M Wasser; R Vink; P D Maaswinkel-Mooy
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

2.  Giant Hepatic Adenoma in a 12-Year-Old Girl.

Authors:  Hemant Kumar Singh; Shraddha Patkar; A M Polnaya; Mukta Ramadwar; Mahesh Goel
Journal:  J Gastrointest Cancer       Date:  2019-03

3.  Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.

Authors:  Peter Bannasch
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

Review 4.  Liver transplantation for glycogen storage disease types I, III, and IV.

Authors:  D Matern; T E Starzl; W Arnaout; J Barnard; J S Bynon; A Dhawan; J Emond; E B Haagsma; G Hug; A Lachaux; G P Smit; Y T Chen
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

Review 5.  Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.

Authors:  Ayelet Erez; Oleg A Shchelochkov; Sharon E Plon; Fernando Scaglia; Brendan Lee
Journal:  Am J Hum Genet       Date:  2011-04-08       Impact factor: 11.025

6.  Liver cell adenoma with malignant transformation: a case report.

Authors:  Masahiro Ito; Makoto Sasaki; Chun Yang Wen; Masahiro Nakashima; Toshihito Ueki; Hiromi Ishibashi; Michitami Yano; Masayoshi Kage; Masamichi Kojiro
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  Liver cell adenoma and liver cell adenomatosis.

Authors:  Ludger Barthelmes; Iain S Tait
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 8.  Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.

Authors:  Elan Hahn; Juan Putra
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

9.  Safety and efficacy of transarterial embolization of hepatocellular adenomas.

Authors:  B V van Rosmalen; A J Klompenhouwer; J Jaap de Graeff; M P D Haring; V E de Meijer; L Rifai; S Dokmak; A Rawashdeh; M Abu Hilal; M C de Jong; C H C Dejong; M Doukas; R A de Man; J N M IJzermans; O M van Delden; J Verheij; T M van Gulik
Journal:  Br J Surg       Date:  2019-07-17       Impact factor: 6.939

10.  Development of Hepatocellular Carcinoma in Patients with Glycogen Storage Disease: a Single Center Retrospective Study.

Authors:  Hyo Jeong Jang; Hye Ran Yang; Jae Sung Ko; Jin Soo Moon; Ju Young Chang; Jeong Kee Seo
Journal:  J Korean Med Sci       Date:  2020-01-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.